doi: 10.3389/fnagi.2025.1601602 Received 28 March 2025 Accepted 03 July 2025 Published 24 July 2025 Volume 17 - 2025 Edited by Rita Machado De Olivera, New University of Lisbon, Portugal Reviewed by Venkateswarlu Kanamarlapudi, Swansea University Medical School, United Kingdom Joon W Shim, Marshall University, United States Updates Copyright 2025 Li, Huang, Wang, Huang, Shi, Luo and Huang
diabetics already face higher risk with smoking, hypertension, dyslipidemia
Semaglutide in Sarasota, FL, is suitable for individuals who have difficulty managing their weight and have not succeeded with other weight loss methods
Well continue to monitor and analyze scientific developments and changes in the nootropics marketplace, updating this page as any information changes